Taiko Pharmaceutical Co.,Ltd.

TSE:4574.T

392 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q4
Revenue 1,9291,3211,1671,6511,5321,2366212,3223,2601,8603,2785,142.8955,675.9084,924.2635,636.4082,959.8761,415.6183,188.1433,416.7732,506.1121,266.6182,739.7343,076.8182,229.0351,392.7792,217.9043,064.7131,949.4041,052.8662,177.1322,876.9191,812.5611,428.6761,897.9833,551.0832,212.871,575.8382,284.0583,417.8552,283.3721,883.0021,732.4562,413.7431,849.7671,419.7771,886.6761,783.2821,634.5051,386.349774.0141,474.4161,285.55936.442731.1262,979.7033,063.681,958.9241,430.5891,853.676
Cost of Revenue 1,1898445931,0498778741,1613,4029162,3841,2711,502.0921,636.5031,804.5381,290.252871.934391.0691,210.456870.662741.098393.5961,157.378562.218730.844435.4521,043.271724.045599.115347.563910.627722.9453.482469.246539.525768.081602.41444.76585.923968.06576.631553.045520.814760.05623.606503.372732.665548.023517.605403.18389.651526.587422.894245.082321.646769.477856.482490.041442.802482.566
Gross Profit 740477574602655362-540-1,0802,344-5242,0073,640.8034,039.4053,119.7254,346.1562,087.9421,024.5491,977.6872,546.1111,765.014873.0221,582.3562,514.61,498.191957.3271,174.6332,340.6681,350.289705.3031,266.5052,154.0191,359.079959.431,358.4582,783.0021,610.461,131.0781,698.1352,449.7951,706.7411,329.9571,211.6421,653.6931,226.161916.4051,154.0111,235.2591,116.9983.169384.363947.829862.656691.36409.482,210.2262,207.1981,468.883987.7871,371.11
Gross Profit Ratio 0.3840.3610.4920.3650.4280.293-0.87-0.4650.719-0.2820.6120.7080.7120.6340.7710.7050.7240.620.7450.7040.6890.5780.8170.6720.6870.530.7640.6930.670.5820.7490.750.6720.7160.7840.7280.7180.7430.7170.7470.7060.6990.6850.6630.6450.6120.6930.6830.7090.4970.6430.6710.7380.560.7420.720.750.690.74
Reseach & Development Expenses 00000000000000000000000000000000000000000000000000000000000
General & Administrative Expenses 00000000000000000000000000000000000000000000000000000000000
Selling & Marketing Expenses 00000000000000000000000000000000000000000000000000000000000
SG&A 00000000000000000000000000000000000000000000000000000000000
Other Expenses -70-687299319861,1091,131-770-360-410-74-57.159-54.581-117.608-63.355-56.878-44.283-50.804-57.184-39.255-40.893-70.092-62.422-63.486-53.06-10.963-53.428-62.962-55.074-31.0990.1063.6334.49812.9033.402-5.13210.0689.963.5393.2265.182.3516.364-0.5176.2917.1696.3713.33614.9426.40123.03851.547.478.204-4.6468.7679.939-3.342-4.083
Operating Expenses 7887187299319861,1091,1312,2891,6421,5662,1972,160.0491,281.9132,498.5492,123.5831,287.964843.6961,845.2571,292.8091,182.553811.2881,608.1681,134.5621,176.891775.8021,388.9311,055.394879.634701.5291,201.8881,268.8251,111.512809.111,328.0841,223.6391,055.266716.7871,726.4171,270.394889.184707.8451,384.954908.143924.99668.8161,471.264950.678817.741734.6521,107.1071,124.189979.794917.684930.4441,008.4521,114.541753.13909.497851.884
Operating Income -48-241-155-329-333-745-1,672-3,369702-2,090-1901,480.7532,757.491621.1752,222.572799.978180.853132.4311,253.301582.4661.734-25.8121,380.039321.299181.524-214.2961,285.273470.6553.77364.616885.194247.566150.3230.3741,559.364555.193414.29-28.2821,179.401817.558622.11-173.313745.551301.172247.587-317.253284.582299.157248.517-722.742-176.36-117.138-226.324-520.9651,201.7731,092.655715.75278.289519.225
Operating Income Ratio -0.025-0.182-0.133-0.199-0.217-0.603-2.692-1.4510.215-1.124-0.0580.2880.4860.1260.3940.270.1280.0420.3670.2320.049-0.0090.4490.1440.13-0.0970.4190.2410.0040.030.3080.1370.1050.0160.4390.2510.263-0.0120.3450.3580.33-0.10.3090.1630.174-0.1680.160.1830.179-0.934-0.12-0.091-0.242-0.7130.4030.3570.3650.0550.28
Total Other Income Expenses Net 3-9-87-1,360-54-303-73-2,965-354-579-42-71.262-54.852-183.877-37.967-44.906-53.50236.27-50.826-6.863-22.524-109.708-93.757-66.754-34.086-62.3132.273-61.916-62.43124.2213.992-160.812-33.571-73.829162.645113.878-3.297-142.69892.039-2.95716.501-71.8352.992-1.6330.03529.21712.271-144.2182.278-1,331.473-2.847-194.412-16.87397.5477.279-11.7067.1694.469-184.608
Income Before Tax -45-250-242-1,689-387-1,048-1,745-6,334348-2,669-2321,409.4912,702.639437.2982,184.605755.072127.351168.7011,202.475575.59739.21-135.521,286.282254.545147.438-276.5961,417.546408.739-58.65888.836899.18686.754116.749-43.4551,722.009669.071410.993-170.981,271.44814.601638.611-245.143798.543299.539247.622-288.036296.853154.939250.795-1,377.213-179.208-196.272-243.198-423.4171,209.0521,080.949722.92182.758334.617
Income Before Tax Ratio -0.023-0.189-0.207-1.023-0.253-0.848-2.81-2.7280.107-1.435-0.0710.2740.4760.0890.3880.2550.090.0530.3520.230.031-0.0490.4180.1140.106-0.1250.4630.21-0.0560.0410.3130.0480.082-0.0230.4850.3020.261-0.0750.3720.3570.339-0.1420.3310.1620.174-0.1530.1660.0950.181-1.779-0.122-0.153-0.26-0.5790.4060.3530.3690.0580.181
Income Tax Expense 321124-3131,311-76-444-85421.104832.262110.718699.421216.45424.26639.746363.947166.3760.422-76.893408.80378.23547.641-74.163420.095119.016-23.33423.294248.01114.03666.073-9.315619.619238.668139.1030.162469.714227.069109.494-35.12810.1686.26181.734-67.269-0.999-47.12547.741-72.51834.732390.084-119.982-140.357463.585406.12215.03312.081117.518
Net Income -48-271-243-1,713-384-1,049-1,748-7,647425-2,225-147988.3871,870.377326.5791,485.184538.619103.084128.954838.528409.22238.787-58.627877.479176.31199.796-202.434997.452289.722-35.32465.542651.17572.71850.675-34.1421,102.391430.402271.89-171.142801.727587.532529.116-210.016788.375293.279165.887-220.767297.854202.064203.053-1,304.695-213.94-586.356-123.215-283.06745.466674.828507.88770.678217.099
Net Income Ratio -0.025-0.205-0.208-1.038-0.251-0.849-2.815-3.2930.13-1.196-0.0450.1920.330.0660.2630.1820.0730.040.2450.1630.031-0.0210.2850.0790.072-0.0910.3250.149-0.0340.030.2260.040.035-0.0180.310.1940.173-0.0750.2350.2570.281-0.1210.3270.1590.117-0.1170.1670.1240.146-1.686-0.145-0.456-0.132-0.3870.250.220.2590.0490.117
EPS 0-5.76-5.57-39.31-8.81-24.07-40.11-243.329.81-51.35-3.3923.0243.567.6134.5912.572.413.0119.579.580.91-1.3720.544.162.36-4.7823.547.41-0.91.6816.661.91.32-0.8928.7411.27.07-4.4520.8615.3913.86-5.520.657.534.26-5.677.655.215.24-34.01-5.58-15.27-3.21-7.419.4817.6313.271.855.67
EPS Diluted 0-5.68-5.57-39.31-8.81-24.07-40.11-188.329.81-51.35-3.3923.0243.287.6134.5912.572.43.0119.579.580.91-1.3720.544.162.35-4.7823.547.41-0.91.6816.661.91.29-0.8928.7411.26.92-4.4520.8615.3913.45-5.520.657.534.2-5.677.655.215.12-34.01-5.58-15.27-3.21-7.419.4817.6313.271.855.67
EBITDA -79-266-240-1,570-401-770-1,746-4,124350-2,709-1911,409.5282,702.715437.3672,184.693755.181127.47942.3611,253.678581.96151.004-25.5031,414.157321.3162.255-166.3021,185.31472.154-29.12-10.156914.422201.916204.132106.2571,501.187555.194414.291108.71,176.594817.557622.112-62.238745.55301.171247.589-313.615284.581438.276250.14719.583-102.63256.685-171.375-527.3541,257.7921,150.276763.134132.445654.921
EBITDA Ratio -0.041-0.201-0.206-0.951-0.262-0.623-2.812-1.7760.107-1.456-0.0580.2740.4760.0890.3880.2550.090.0130.3670.2320.04-0.0090.460.1440.116-0.0750.3870.242-0.028-0.0050.3180.1110.1430.0560.4230.2510.2630.0480.3440.3580.33-0.0360.3090.1630.174-0.1660.160.2680.180.025-0.070.044-0.183-0.7210.4220.3750.390.0930.353